RED CELL MEMBRANE PROTEIN 4.1--STRUCTURE AND FUNCTION
红细胞膜蛋白 4.1--结构与功能
基本信息
- 批准号:6564216
- 负责人:
- 金额:$ 14.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-01-01 至 2002-03-31
- 项目状态:已结题
- 来源:
- 关键词:artificial chromosomes erythrocyte membrane gene expression gene rearrangement gene targeting genetic mapping hereditary elliptocytosis human genetic material tag human tissue membrane proteins molecular cloning nucleic acid sequence protein 4.1 protein isoforms protein structure function protein transport
项目摘要
The about 80kD erythroid membrane skeletal component, protein 4.1, is
the prototypical member of a complex family of structural protein
isoforms encoded by a single genetic locus via multiple alternative pre-
mRNA splicing pathways. Whereas the structure of the major red cell 4.1
isoforms has been defined, and some of its functional domains well
characterized, a molecular genetic explanation for the diversity in 4.1
size (30-210kD) and intracellular localization (peripheral membranes,
stress fibers, nuclei, centrosomes, Golgi) is lacking. In order to
completely define the genetic repertoire of the 4.1 gene, and to
characterize developmental switched in 4.1 expression mediated by
regulated transcription and splicing events, the following aims are
proposed. (1) Determine the DNA sequence of the entire about 250kb
human 4.1 gene locus, to provide a wealth of primary data essential for
analysis of gene function in normal individuals and in selected patients
with hereditary elliptocytosis. (2) Explore the structural determinants
of 4.1 isoform localization, by (a) characterizing transcription- and
splicing-mediated changes in the complement of 4.1 mRNAs expressed in
differentiating erythroid and epithelial cells, and (b) determining the
subcellular compartmentalization of individual epitope-tagged isoforms
of known primary sequence. (3) Develop genetic approaches toward
manipulation of 4.1 expression in tissue-specific and isoform-specific
fashion, by generating mice with 4.1 gene disruptions and
rearrangements. 4.1 gene knockouts by homologous recombination in ES
cells, and gene rescue experiments with normal or mutated YAC
transgenes, are proposed to explore the biological significance of
selected isoforms or functional domains. Studies will focus primarily
on erythroid and epithelial cells, in which regulated switches in 4.1
expression have been demonstrated, and on fibroblasts, in which nuclear
4.1 isoforms have been identifies. The protein 4.1 gene will serve as a
valuable model for exploring tissue-specific expression of a large and
highly complex gene encoding a critical component of multiple
intracellular skeletal structures. Successful accomplishment of these
aims will facilitate elucidation of the biological functional
significance of this diverse protein family, and may provide insight
into the pathophysiologic consequences of disruptions in 4.1 gene
expression.
约 80kD 的红细胞膜骨骼成分,蛋白质 4.1,是
结构蛋白复杂家族的典型成员
同种型由单个遗传位点通过多个替代预编码编码
mRNA 剪接途径。 而主要红细胞的结构 4.1
同工型已经被定义,并且它的一些功能域得到了很好的定义
4.1 多样性的分子遗传学解释
大小(30-210kD)和细胞内定位(外周膜,
缺乏应力纤维、细胞核、中心体、高尔基体)。 为了
完整定义了4.1基因的遗传库,并
4.1 表达介导的发育转换特征
调控转录和剪接事件,以下目标是
建议的。 (1)确定整个约250kb的DNA序列
人类4.1基因位点,提供丰富的重要原始数据
正常个体和选定患者的基因功能分析
患有遗传性椭圆形红细胞增多症。 (2)探索结构性决定因素
4.1 同工型定位,通过 (a) 表征转录和
4.1 mRNA 补体中剪接介导的变化
区分红细胞和上皮细胞,以及 (b) 确定
单个表位标记亚型的亚细胞区室化
已知的一级序列。 (3) 开发遗传方法
4.1 组织特异性和异构体特异性表达的操作
时尚,通过产生具有 4.1 基因破坏的小鼠和
重新安排。 4.1 ES同源重组基因敲除
使用正常或突变的 YAC 进行细胞和基因拯救实验
转基因,旨在探索其生物学意义
选定的亚型或功能域。 研究将主要集中于
对红细胞和上皮细胞的影响,其中 4.1 中的调节开关
表达已被证明,并且在成纤维细胞上,其中核
4.1 同种型已被鉴定。 蛋白质4.1基因将作为
探索大的组织特异性表达的有价值的模型
高度复杂的基因编码多个关键组成部分
细胞内骨骼结构。 成功实现这些
目标将有助于阐明生物功能
这种多样化蛋白质家族的重要性,并可能提供见解
4.1 基因破坏的病理生理后果
表达。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN G CONBOY其他文献
JOHN G CONBOY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN G CONBOY', 18)}}的其他基金
Intron Retention Mechanisms that Regulate Erythroid SF3B1 Gene Expression
调节红细胞 SF3B1 基因表达的内含子保留机制
- 批准号:
9307813 - 财政年份:2016
- 资助金额:
$ 14.33万 - 项目类别:
Aberrant RNA processing in MBNL1-deficient mice with erythroid defects
MBNL1 缺陷型红细胞缺陷小鼠的 RNA 加工异常
- 批准号:
9115135 - 财政年份:2014
- 资助金额:
$ 14.33万 - 项目类别:
Aberrant RNA processing in MBNL1-deficient mice with erythroid defects
MBNL1 缺陷型红细胞缺陷小鼠的 RNA 加工异常
- 批准号:
8613315 - 财政年份:2014
- 资助金额:
$ 14.33万 - 项目类别:
Erythroid stage-specific transcriptome expression, dynamics, and regulation
红系阶段特异性转录组表达、动态和调控
- 批准号:
8335204 - 财政年份:2011
- 资助金额:
$ 14.33万 - 项目类别:
Erythroid stage-specific transcriptome expression, dynamics, and regulation
红系阶段特异性转录组表达、动态和调控
- 批准号:
8728222 - 财政年份:2011
- 资助金额:
$ 14.33万 - 项目类别:
Erythroid stage-specific transcriptome expression, dynamics, and regulation
红系阶段特异性转录组表达、动态和调控
- 批准号:
8543725 - 财政年份:2011
- 资助金额:
$ 14.33万 - 项目类别:
Erythroid stage-specific transcriptome expression, dynamics, and regulation
红系阶段特异性转录组表达、动态和调控
- 批准号:
8258173 - 财政年份:2011
- 资助金额:
$ 14.33万 - 项目类别:
Red Cell Band 4.1 - Developmental Changes in RNA Splicing
红细胞带 4.1 - RNA 剪接的发育变化
- 批准号:
7894777 - 财政年份:2009
- 资助金额:
$ 14.33万 - 项目类别:
Red Cell Band 4.1 - Developmental Changes in RNA Splicing
红细胞带 4.1 - RNA 剪接的发育变化
- 批准号:
7533943 - 财政年份:2009
- 资助金额:
$ 14.33万 - 项目类别:
Programmed Changes in Alternative Splicing Within Erythr
Erythr 内选择性剪接的程序化变化
- 批准号:
7087238 - 财政年份:2006
- 资助金额:
$ 14.33万 - 项目类别:
相似海外基金
Identification of parasite erythrocyte membrane antigens specific to cerebral malaria and severe malarial anemia pathogenesis
脑型疟疾特异性寄生虫红细胞膜抗原的鉴定和严重疟疾贫血发病机制
- 批准号:
9981421 - 财政年份:2019
- 资助金额:
$ 14.33万 - 项目类别:
Identification of parasite erythrocyte membrane antigens specific to cerebral malaria and severe malarial anemia pathogenesis
脑型疟疾特异性寄生虫红细胞膜抗原的鉴定和严重疟疾贫血发病机制
- 批准号:
9755113 - 财政年份:2019
- 资助金额:
$ 14.33万 - 项目类别:
Screening of colorectal cancer through the detection of erythrocyte membrane bound IgG
通过检测红细胞膜结合IgG筛查结直肠癌
- 批准号:
18K07297 - 财政年份:2018
- 资助金额:
$ 14.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeted Erythrocyte Membrane-Coated Nanoparticles for the Treatment of AML
靶向红细胞膜包被的纳米颗粒用于治疗 AML
- 批准号:
8912271 - 财政年份:2014
- 资助金额:
$ 14.33万 - 项目类别:
Targeted Erythrocyte Membrane-Coated Nanoparticles for the Treatment of AML
靶向红细胞膜包被的纳米颗粒用于治疗 AML
- 批准号:
8715271 - 财政年份:2014
- 资助金额:
$ 14.33万 - 项目类别:
Erythrocyte Membrane Fatty Acid Concentrations and Myelin Integrity in Young People at Ultra-High Risk of Psychosis
精神病超高风险年轻人的红细胞膜脂肪酸浓度和髓磷脂完整性
- 批准号:
nhmrc : 1067040 - 财政年份:2014
- 资助金额:
$ 14.33万 - 项目类别:
Project Grants
Wrong parasite, wrong host? How Plasmodium falciparum erythrocyte membrane protein 1 expression and the host’s innate immune response combine to influence the inflammatory response to malaria in vitro and in vivo. Implications for severe malaria
错误的寄生虫,错误的宿主?
- 批准号:
nhmrc : 1061993 - 财政年份:2014
- 资助金额:
$ 14.33万 - 项目类别:
Project Grants
Suppression of immunity by the malaria parasite antigen Plasmodium falciparum Erythrocyte Membrane Protein-1 (PfEMP-1)
疟疾寄生虫抗原恶性疟原虫红细胞膜蛋白 1 (PfEMP-1) 对免疫的抑制
- 批准号:
nhmrc : 1038030 - 财政年份:2012
- 资助金额:
$ 14.33万 - 项目类别:
Postgraduate Scholarships
Development of a simple activity measurement method for erythrocyte membrane-derived Na+/K+-ATPase for its application in medical technology.
开发一种简单的红细胞膜来源的 Na /K -ATP 酶活性测量方法,用于医疗技术中的应用。
- 批准号:
24590702 - 财政年份:2012
- 资助金额:
$ 14.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Osmotic fragility of erythrocyte membrane caused by the change of Band 3
Band 3变化引起的红细胞膜渗透脆性
- 批准号:
23650407 - 财政年份:2011
- 资助金额:
$ 14.33万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research